Discover J&J’s pipeline strategy for 2026 as it it projects that its sales for the year will be between $100 billion and $101 ...
UK biotech showed resilience in a tough 2025 for healthcare funding, suggesting investor interest could grow in 2026.
Discover how a newly developed platform technology from The University of North Carolina at Chapel Hill can enhance RNAi ...
From Dupixent to Tezspire and verekitug, explore emerging sinusitis treatments and the race to improve chronic rhinosinusitis ...
Delve into what 2026 has to offer in the biotech industry. The market is showing signs it's picking up and the patent cliff ...
Explore how leadership in biotech drives success through a milestone approach, aligning teams and culture from science to ...
Stay updated on biotech layoffs in 2026! Each week, we track and analyze industry layoffs, their causes, and their impact.
This year, JPM 2026 took place again in San Francisco. Let’s look at predictions and trends forecast for 2026, according to ...
Discover how platformed lentiviral manufacturing and ready-to-deploy CAR-T solutions are breaking the critical barriers of ...
Since its spin-out from Abbott in 2013, AbbVie’s pipeline strategy has been built around a dominant immunology franchise anchored by Humira. For much of the past decade, that formula worked very well.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results